IRADIMED CORPORATION Capitalized Contract Cost, Net
IRADIMED CORPORATION (IRMD) had Capitalized Contract Cost, Net of $244.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Assets
us-gaap:CapitalizedContractCostNet · last filed 2026-07-31
- 2026-06-30: Capitalized Contract Cost, Net $244.00K.
- 2026-03-31: Capitalized Contract Cost, Net $225.00K.
- 2025-12-31: Capitalized Contract Cost, Net $239.00K.
- 2025-09-30: Capitalized Contract Cost, Net $214.37K.
| Period end | Capitalized Contract Cost, Net | Capitalized Contract Cost, Net as first filed |
|---|---|---|
| 2026-06-30 | $244.00K 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $225.00K 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $239.00K 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $214.37K 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $199.89K 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $192.09K 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $180.00K 10-K · filed 2026-03-06 | $179.60K 10-K · filed 2025-03-06 |
| 2024-09-30 | $164.90K 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $168.92K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $165.39K 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $162.13K 10-K/A · filed 2025-09-03 | |
| 2023-09-30 | $125.28K 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $199.78K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $320.75K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $340.04K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $351.15K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $347.39K 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $318.33K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $357.81K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $360.92K 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $353.94K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $352.31K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $384.37K 10-K · filed 2022-03-04 | |
| 2020-09-30 | $362.12K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $378.65K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $412.86K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $352.25K 10-K · filed 2021-03-05 | |
| 2019-09-30 | $331.63K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $192.08K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $186.14K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $181.25K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $188.59K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $189.07K 10-Q · filed 2018-08-08 | |
| 2017-12-31 | $168.76K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |